TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

Benzinga Logo Benzinga By Globe Newswire
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

CytoMed Therapeutics has completed the acquisition of allogeneic gamma delta T cell technology from TC BioPharm, aiming to develop cancer treatments for China and India. The technology has completed a Phase I clinical trial and received FDA orphan drug designation for Acute Myeloid Leukemia.

Insights
GOOGL   neutral

Increasing use of proprietary Tensor Processing Units, which could challenge Nvidia's market dominance


GDTC   positive

Company is expanding its technology portfolio, pursuing strategic international collaborations, and advancing its cancer treatment platform